A new off-ramp from Ozempic and Wegovy? (opens in new tab)

Fractyl Health reports one-year data suggesting patients may maintain weight loss after stopping GLP-1 drugs. Obesity medicine’s problem is not a weight-loss problem – that appears increasingly solvable thanks to blockbuster GLP-1 drugs such as Ozempic and Wegovy. The real challenge begins afterward. What happens when people stop taking them? For many patients, that’s not […] The post appeared first on <a href="